From: A community pharmacy weight management programme: an evaluation of effectiveness
Number of patients | Percentage (95% CI*) of patients who attended | Mean (95% CI*) weight loss (kg) | Percentage (95% CI*) of patients losing ≥5% of baseline weight | |||||
---|---|---|---|---|---|---|---|---|
Attending patients | BOCF** | LOCF*** | Attending patients | BOCF** | LOCF*** | |||
Sex | ||||||||
Men | 79 | 29.1 (19.4, 40.4) | 5.79 (2.47, 9.10) | 1.69 (0.58, 2.79) | 2.53 (1.41, 3.56) | 39.1 (19.7, 61.5) | 9.8 (6.3, 14.4) | 17.7 (10.0, 27.9) |
Women | 234 | 23.1 (1.78, 29.0) | 3.41 (2.25, 4.57) | 0.79 (0.47, 1.11) | 1.46 (1.05, 1.86) | 42.6 (29.2, 56.8) | 11.4 (5.3, 20.5) | 15.4 (11.0, 20.7) |
p value | 0.28 | 0.66 | 0.62 | 0.21 | 0.78 | 0.69 | 0.62 | |
Age group (years) | ||||||||
40-49 | 61 | 19.7 (10.6, 31.8) | 4.78 (1.50, 8.06) | 0.94 (0.16, 1.72) | 1.49 (0.56, 2.43) | 50.0 (21.1, 78.9) | 9.8 (3.7, 20.2) | 16.4 (8.2, 28.1) |
50-59 | 134 | 24.6 (17.6, 32.8) | 3.50 (1.40, 5.59) | 0.86 (0.30, 1.43) | 1.66 (1.01, 2.32) | 39.4 (22.9, 57.9) | 9.7 (5.3, 16.0) | 15.7 (10.0, 23.0) |
60+ | 111 | 27.9 (19.8, 37.2) | 4.29 (2.36, 6.22) | 1.20 (0.56, 1.84) | 1.91 (1.22, 2.61) | 38.7 (21.8, 57.8) | 10.8 (5.7, 18.1) | 16.2 (9.9, 24.4) |
p value | 0.49 | 0.66 | 0.77 | 0.57 | 0.78 | 0.96 | 0.99 | |
BMI grouping (kg/m 2 ) | ||||||||
<30 | 30 | 26.7 (12.3, 45.9) | 5.37 (2.35, 8.38) | 1.43 (0.24, 2.63) | 2.02 (0.78, 3.25) | 75.0 (34.9, 96.8) | 20.0 (7.7, 38.6) | 23.3 (9.9, 42.3) |
30- < 35 | 136 | 25.7 (18.6, 33.9) | 2.61 (1.35, 3.88) | 0.67 (0.30, 1.05) | 1.40 (0.89, 1.91) | 37.1 (21.5, 55.1) | 9.6 (5.2, 15.8) | 16.2 (10.4, 23.5) |
35- < 40 | 80 | 23.8 (14.9, 34.6) | 3.82 (1.09, 6.55) | 0.91 (0.17, 1.64) | 1.66 (0.84, 2.48) | 31.6 (12.6, 56.6) | 7.5 (2.8, 15.6) | 13.8 (7.1, 23.3) |
40+ | 64 | 23.4 (13.8, 35.7) | 7.35 (3.08, 11.63) | 1.72 (0.47, 2.98) | 2.39 (1.08, 3.70) | 46.7 (21.3, 73.4) | 10.9 (4.5, 21.2) | 15.6 (7.8, 26.9) |
p value | 0.97 | 0.21 | 0.74 | 0.91 | 0.18 | 0.28 | 0.68 |